Genmont Biotech Inc. logo

Genmont Biotech Inc. (3164)

Market Closed
15 Jun, 05:30
TWSE TWSE
NT$
16. 40
0
0%
NT$
1.59B Market Cap
- P/E Ratio
0.8% Div Yield
31,155 Volume
- Eps
NT$ 16.4
Previous Close
Add Transaction
Day Range
16.3 16.45
Year Range
16 22.4
Want to track 3164 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

3164 closed today higher at NT$16.4, an increase of 0% from yesterday's close, completing a monthly decrease of -1.7964% or -NT$0.3. Over the past 12 months, 3164 stock lost -9.6419%.
3164 pays dividends to its shareholders, with the most recent payment made on May 08, 2026. The next estimated payment will be in In 10 months on May 08, 2027 for a total of NT$0.8.
The last earnings report, released on May 29, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.038%, based on the last three reports.
Genmont Biotech Inc. has completed 5 stock splits, with the recent split occurring on Sep 04, 2014.
The company's stock is traded on one exchange.

3164 Chart

People also search for

Chunghwa Chemical Synthesis & Biotech Co., Ltd.
NT$ 35.35
+1.8732%
Chang Type Industrial Co., Ltd.
NT$ 20.85
+0.2404%
Sheh Fung Screws Co., Ltd.
NT$ 35
+1.4493%
Taiwan Name Plate Co., Ltd.
NT$ 35.05
+0.2861%
Sinher Technology Inc.
NT$ 20.5
+0.2445%

Genmont Biotech Inc. (3164) FAQ

What is the stock price today?

The current price is NT$16.40.

On which exchange is it traded?

Genmont Biotech Inc. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 3164.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 1.59B.

Has Genmont Biotech Inc. ever had a stock split?

Genmont Biotech Inc. had 5 splits and the recent split was on Sep 04, 2014.

Genmont Biotech Inc. Profile

Biotechnology Industry
Healthcare Sector
- CEO
TWSE Exchange
TW0003164000 ISIN
Taiwan Country
- Employees
8 Apr 2026 Last Dividend
4 Sep 2014 Last Split
- IPO Date

Overview

GenMont Biotech Incorporation, established in 2000, operates from its headquarters in Tainan City, Taiwan, focusing on the research, development, manufacture, and sale of functional probiotic supplements. The company has carved a niche for itself in Taiwan's biotech industry by specializing in probiotic solutions designed for various health-related applications, ensuring a broad market appeal. Throughout its operational history spanning over two decades, GenMont Biotech has committed itself to advancing health and wellness through innovative biotechnological research and product development.

Products and Services

  • Functional Probiotics Raw Materials: These are the essential ingredients supplied by GenMont Biotech for the development of probiotic products. Rich in beneficial bacteria, these raw materials form the backbone of various health supplements aimed at improving gut health, boosting immunity, and enhancing overall well-being.
  • Capsules, Powder, Tablets, and Liquid Products: GenMont Biotech offers its functional probiotics in a variety of forms to suit different consumer preferences and requirements. These include easy-to-swallow capsules, versatile powders you can mix into foods or drinks, convenient tablets for those on-the-go, and liquid products for those who prefer a more readily absorbable form.
  • Original Formula Design and Manufacturing: Catering to businesses looking for tailored health solutions, GenMont provides custom formulation services. This encompasses the design and manufacturing of unique health care food products based on specific customer requirements, leveraging the company's extensive experience in probiotic product development.
  • Equipment Manufacturing Services on Health Care Food: Beyond formulating and manufacturing probiotics, GenMont Biotech also offers equipment manufacturing services. These services cater to the production needs of health care food industries, underlining the company's role in providing comprehensive solutions right from product conceptualization to actual production setup.
  • Cooperation in Research, Production, and Clinical Trials: GenMont Biotech engages in various cooperative ventures involving the research, production, and clinical testing of different products. Through these collaborations, the company furthers its mission to develop scientifically backed, efficacious probiotics solutions that contribute to human health.

Contact Information

Address: No.8, Nanke 7th Road
Phone: 886 6 505 2151